XML 23 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value of Financial Instruments
6 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Value of Financial Instruments

The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three level hierarchy. These levels are:

Level 1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2 - Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3 - Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

Observable inputs are based on market data obtained from independent sources.

In May 2016 we issued warrants to purchase 53,619 shares of common stock. Using a binomial pricing model, we valued the warrants at $256 thousand and $204 thousand as of March 31, 2017 and September 30, 2016, respectively.

Assumptions used in valuing the warrants as of March 31, 2017 included:
Risk free interest rate
1.68
%
Contractual term
5 years

Dividend yield
%
Expected lives
4.1 years

Expected volatility
144
%
Fair value per warrant
$5.29


The Company recorded a benefit on the revaluation of the warrant liability of $27 thousand for the quarter ended March 31, 2017. For the six months ended March 31, 2017 the company recorded a charge of $52 thousand related to the revaluation of the warranty liability. The benefit is recorded and classified in other income (expense) in the accompanying consolidated statements of operations.

The Company has issued warrants to purchase stock as described above. The fair value of the warrants was estimated by management in the absence of a readily ascertainable market value as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2016
 
Level 1
 
 
 
Level 2
 
 
 
Level 3
 
 
Warrant issued to acquire common stock
$

 
 
$

 
 
$
283

 
 
 
 
 
 
 
 
 
 
 
 
 
 
March 31, 2017
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Warrant issued to acquire common stock
$
0
 
 
$
0
 
 
$
256

 
 
 
 
 
 
 


Change in Level 3 liabilities for the year ended March 31, 2017:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beginning Balance
 
Realized/Unrealized
 
Purchases and
 
Ending Balance
 
 
Change in Realized (gains) losses for liabilities held at
 
September 30, 2016
 
(Gains) Losses
 
Settlements
 
March 31, 2017
 
 
March 31, 2017
Warrant issued to acquire common stock
$
204

 
 
$
52

 
 
$

 
 
$
256

 
 
 
$
52

 
 
 
 
 
 
 
 
 
 
 
 


The Company has other financial instruments, including accounts receivable, accounts payable, loan payable, notes payable, and accrued expense. Due to the short term nature of these instruments, DLH estimates that the fair value of all financial instruments at March 31, 2017 and September 30, 2016 does not differ materially from the aggregate carrying values of these financial instruments recorded in the accompanying consolidated balance sheets.